
Chiara Corti/LinkedIn
Apr 6, 2025, 14:47
Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer
Chiara Corti, Research Fellow at Dana-Farber Cancer Institute, shared a post on X:
“From immunotherapy (IO) failures to new strategies and biotech innovations in metastatic TNBC, to IO timing, chemo backbones, and novel approaches in the early stage.
All this and more in our latest review on immune checkpoint inhibitors in TNBC”
Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer
Authors: Chiara Corti, Beyza Koca, Tasnim Rahman, Elizabeth A Mittendorf, Sara M Tolaney
More posts featuring Chiara Corti.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 6, 2025, 14:30
Apr 6, 2025, 14:23
Apr 6, 2025, 14:10
Apr 6, 2025, 13:57
Apr 6, 2025, 13:40